Development of Antifungals of Clinical Importance

Award Information
Agency:
Department of Health and Human Services
Amount:
$162,637.00
Program:
SBIR
Contract:
1R43AI058439-01
Solitcitation Year:
2004
Solicitation Number:
PHS2004-2
Branch:
N/A
Award Year:
2004
Phase:
Phase I
Agency Tracking Number:
AI058439
Solicitation Topic Code:
N/A
Small Business Information
SYNVAX, INC.
SYNVAX, INC., 1770 N RESEARCH PKWY, STE 125, NORTH LOGAN, UT, 84341
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 AMRIT Judd
 (435) 713-4917
 SYNVAX@AOL.COM
Business Contact
 AMRIT JUDD
Phone: (435) 713-4917
Email: SYNVAX@AOL.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Fungal infections have increased dramatically in recent years to become important causes of mortality in hospitalized patients. The increase in life-threatening fungal infections has brought about an increased use of

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government